RA

Richard Allman

Cleo Diagnostics Ltd | Chief Executive Officer, Managing Director
Dr Allman has over 30 years of scientific research leadership and innovation with a clear focus on commercialisation. He has experience in research leadership, innovation management, and intellectual property strategy, covering oncology, diagnostics, and product development.

Company and Roles

Company
Title
Tenure
Since
COV
Cleo Diagnostics Ltd
  • Chief Executive Officer
  • Managing Director
4yrsOct 2022

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
COV
Cleo Diagnostics Ltd
24/08/261,727,273N/A2,272,727N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
COV
Cleo Diagnostics Ltd
24/08/26
Exercise
227,273$0.340$77,272Exercise of options
COV
Cleo Diagnostics Ltd
24/08/26
Exercise
227,273$0.340$77,272Exercise of options
COV
Cleo Diagnostics Ltd
24/08/26
Expiry
2,272,727$0.340$772,727Options expired